KRAS G12D inhibitor 3
KRAS G12D Inhibitor 3 is a potent small molecule targeting the KRAS G12D oncogenic mutation, exhibiting an IC50 below 500 nM. It is a valuable research tool for investigating KRAS-driven cancers in both in vitro cellular assays and in vivo animal models.
Product Specifications
CAS Number
2757095-11-5
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
C (OC=1N=C (C2=C (N1) C (F) =C (C (Cl) =C2) C=3C4=C (C=CC (F) =C4C#C) C=C (O) C3) N5CC6NC (C5) CC6) [C@@]78N (C[C@H] (F) C7) CCC8
Molecular Formula
C34H31ClF3N5O2
Molecular Weight
634.09
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740352-100 1x 100 µL
CD31 / PECAM-1 (158-2B3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402848-100 1x 100 µL
Fibronectin (Fn-3), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880304-100 1x 100 µL
CD106 / VCAM1 (B-K9), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881073-100 1x 100 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882216-500 1x 500 µL
CD50 / ICAM3 (CG106), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 